nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—peripheral nervous system neoplasm	0.451	0.857	CbGaD
Acetylsalicylic acid—ABCB1—peripheral nervous system neoplasm	0.075	0.143	CbGaD
Acetylsalicylic acid—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0248	0.126	CbGbCtD
Acetylsalicylic acid—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0218	0.111	CbGbCtD
Acetylsalicylic acid—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0214	0.109	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0181	0.092	CbGbCtD
Acetylsalicylic acid—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0181	0.0918	CbGbCtD
Acetylsalicylic acid—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0181	0.0918	CbGbCtD
Acetylsalicylic acid—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0173	0.088	CbGbCtD
Acetylsalicylic acid—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0125	0.0637	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0104	0.0531	CbGbCtD
Acetylsalicylic acid—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00771	0.0392	CbGbCtD
Acetylsalicylic acid—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00741	0.0377	CbGbCtD
Acetylsalicylic acid—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00719	0.0366	CbGbCtD
Acetylsalicylic acid—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00706	0.0359	CbGbCtD
Acetylsalicylic acid—TP53—skull—peripheral nervous system neoplasm	0.00557	0.112	CbGeAlD
Acetylsalicylic acid—TP53—forelimb—peripheral nervous system neoplasm	0.00536	0.108	CbGeAlD
Acetylsalicylic acid—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00482	0.0245	CbGbCtD
Acetylsalicylic acid—TP53—arm—peripheral nervous system neoplasm	0.00461	0.0924	CbGeAlD
Acetylsalicylic acid—TP53—manus—peripheral nervous system neoplasm	0.00411	0.0823	CbGeAlD
Acetylsalicylic acid—TP53—manual digit—peripheral nervous system neoplasm	0.00402	0.0806	CbGeAlD
Acetylsalicylic acid—NFKBIA—nerve—peripheral nervous system neoplasm	0.00289	0.0579	CbGeAlD
Acetylsalicylic acid—HSPA5—nerve—peripheral nervous system neoplasm	0.00283	0.0567	CbGeAlD
Acetylsalicylic acid—HSPA5—ganglion—peripheral nervous system neoplasm	0.00279	0.056	CbGeAlD
Acetylsalicylic acid—TP53—trigeminal ganglion—peripheral nervous system neoplasm	0.00142	0.0286	CbGeAlD
Acetylsalicylic acid—NFKBIA—trigeminal ganglion—peripheral nervous system neoplasm	0.0014	0.0281	CbGeAlD
Acetylsalicylic acid—HSPA5—trigeminal ganglion—peripheral nervous system neoplasm	0.00137	0.0275	CbGeAlD
Acetylsalicylic acid—NFKBIA—parotid gland—peripheral nervous system neoplasm	0.00132	0.0265	CbGeAlD
Acetylsalicylic acid—HSPA5—parotid gland—peripheral nervous system neoplasm	0.00129	0.026	CbGeAlD
Acetylsalicylic acid—TP53—brainstem—peripheral nervous system neoplasm	0.00126	0.0253	CbGeAlD
Acetylsalicylic acid—NFKBIA—brainstem—peripheral nervous system neoplasm	0.00124	0.0249	CbGeAlD
Acetylsalicylic acid—HSPA5—brainstem—peripheral nervous system neoplasm	0.00121	0.0244	CbGeAlD
Acetylsalicylic acid—RPS6KA3—trigeminal ganglion—peripheral nervous system neoplasm	0.00117	0.0234	CbGeAlD
Acetylsalicylic acid—RPS6KA3—parotid gland—peripheral nervous system neoplasm	0.0011	0.0221	CbGeAlD
Acetylsalicylic acid—EDNRA—trigeminal ganglion—peripheral nervous system neoplasm	0.00095	0.0191	CbGeAlD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000835	0.247	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000633	0.188	CbGdCrCtD
Acetylsalicylic acid—TP53—cerebellum—peripheral nervous system neoplasm	0.000621	0.0125	CbGeAlD
Acetylsalicylic acid—NFKBIA—cerebellum—peripheral nervous system neoplasm	0.000611	0.0123	CbGeAlD
Acetylsalicylic acid—HSPA5—cerebellum—peripheral nervous system neoplasm	0.000599	0.012	CbGeAlD
Acetylsalicylic acid—PTGS1—ganglion—peripheral nervous system neoplasm	0.000584	0.0117	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cerebellum—peripheral nervous system neoplasm	0.00051	0.0102	CbGeAlD
Acetylsalicylic acid—IKBKB—cerebellum—peripheral nervous system neoplasm	0.000376	0.00755	CbGeAlD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.00033	0.0978	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.00033	0.0978	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.00033	0.0978	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.0905	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.0905	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.0905	CbGdCrCtD
Acetylsalicylic acid—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	0.000274	0.0055	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000199	0.00169	CcSEcCtD
Acetylsalicylic acid—Shock—Isotretinoin—peripheral nervous system neoplasm	0.000199	0.00168	CcSEcCtD
Acetylsalicylic acid—Shock—Tretinoin—peripheral nervous system neoplasm	0.000199	0.00168	CcSEcCtD
Acetylsalicylic acid—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00168	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.00167	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000198	0.00167	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000197	0.00167	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000197	0.00167	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000197	0.00166	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000195	0.00165	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000195	0.00165	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000195	0.00165	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000195	0.00165	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00159	CcSEcCtD
Acetylsalicylic acid—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.00158	CcSEcCtD
Acetylsalicylic acid—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00155	CcSEcCtD
Acetylsalicylic acid—Melaena—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00155	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000182	0.00154	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000181	0.00153	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00018	0.00152	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00018	0.00152	CcSEcCtD
Acetylsalicylic acid—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00018	0.00152	CcSEcCtD
Acetylsalicylic acid—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00018	0.00152	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000179	0.00152	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000178	0.0015	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000178	0.0015	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000178	0.0015	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000176	0.00148	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00147	CcSEcCtD
Acetylsalicylic acid—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.00147	CcSEcCtD
Acetylsalicylic acid—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00146	CcSEcCtD
Acetylsalicylic acid—Coma—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00145	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000171	0.00145	CcSEcCtD
Acetylsalicylic acid—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00017	0.00144	CcSEcCtD
Acetylsalicylic acid—Melaena—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00143	CcSEcCtD
Acetylsalicylic acid—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.00017	0.0034	CbGeAlD
Acetylsalicylic acid—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.00142	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000168	0.00142	CcSEcCtD
Acetylsalicylic acid—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000167	0.00141	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000166	0.00141	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000166	0.00141	CcSEcCtD
Acetylsalicylic acid—Agitation—Vincristine—peripheral nervous system neoplasm	0.000166	0.0014	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.00139	CcSEcCtD
Acetylsalicylic acid—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.00137	CcSEcCtD
Acetylsalicylic acid—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000162	0.00137	CcSEcCtD
Acetylsalicylic acid—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.00137	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000162	0.00137	CcSEcCtD
Acetylsalicylic acid—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000162	0.00137	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.00137	CcSEcCtD
Acetylsalicylic acid—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00016	0.00136	CcSEcCtD
Acetylsalicylic acid—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00016	0.00136	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.00135	CcSEcCtD
Acetylsalicylic acid—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.00135	CcSEcCtD
Acetylsalicylic acid—Coma—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00134	CcSEcCtD
Acetylsalicylic acid—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000158	0.00134	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00132	CcSEcCtD
Acetylsalicylic acid—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000157	0.00132	CcSEcCtD
Acetylsalicylic acid—Flushing—Etoposide—peripheral nervous system neoplasm	0.000156	0.00132	CcSEcCtD
Acetylsalicylic acid—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000156	0.00132	CcSEcCtD
Acetylsalicylic acid—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.00131	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.00129	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00129	CcSEcCtD
Acetylsalicylic acid—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.00127	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00015	0.00127	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.00127	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.00126	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000149	0.00126	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000149	0.00126	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.00125	CcSEcCtD
Acetylsalicylic acid—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000148	0.00125	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000148	0.00125	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000147	0.00124	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00123	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000144	0.00122	CcSEcCtD
Acetylsalicylic acid—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000144	0.00122	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00121	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000143	0.00121	CcSEcCtD
Acetylsalicylic acid—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000143	0.00121	CcSEcCtD
Acetylsalicylic acid—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000143	0.00121	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000143	0.00121	CcSEcCtD
Acetylsalicylic acid—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000141	0.0012	CcSEcCtD
Acetylsalicylic acid—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000141	0.00119	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00119	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00118	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000139	0.00118	CcSEcCtD
Acetylsalicylic acid—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000138	0.00117	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000138	0.00117	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000138	0.00117	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.00115	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000136	0.00115	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00115	CcSEcCtD
Acetylsalicylic acid—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.00115	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000136	0.00115	CcSEcCtD
Acetylsalicylic acid—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000135	0.00114	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.00114	CcSEcCtD
Acetylsalicylic acid—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000135	0.00114	CcSEcCtD
Acetylsalicylic acid—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000134	0.00113	CcSEcCtD
Acetylsalicylic acid—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000134	0.00113	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00112	CcSEcCtD
Acetylsalicylic acid—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000132	0.00111	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000131	0.00111	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00111	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00013	0.0011	CcSEcCtD
Acetylsalicylic acid—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000129	0.00109	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00109	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000129	0.00109	CcSEcCtD
Acetylsalicylic acid—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000128	0.00109	CcSEcCtD
Acetylsalicylic acid—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000128	0.00109	CcSEcCtD
Acetylsalicylic acid—Rash—Topotecan—peripheral nervous system neoplasm	0.000128	0.00109	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000128	0.00108	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000128	0.00108	CcSEcCtD
Acetylsalicylic acid—Rash—Tretinoin—peripheral nervous system neoplasm	0.000127	0.00108	CcSEcCtD
Acetylsalicylic acid—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000127	0.00108	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000127	0.00108	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000127	0.00108	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000127	0.00108	CcSEcCtD
Acetylsalicylic acid—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000127	0.00107	CcSEcCtD
Acetylsalicylic acid—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000127	0.00107	CcSEcCtD
Acetylsalicylic acid—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000126	0.00107	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.00107	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00107	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000126	0.00107	CcSEcCtD
Acetylsalicylic acid—Rash—Melphalan—peripheral nervous system neoplasm	0.000126	0.00106	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000126	0.00106	CcSEcCtD
Acetylsalicylic acid—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000125	0.00105	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00105	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000122	0.00103	CcSEcCtD
Acetylsalicylic acid—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.00103	CcSEcCtD
Acetylsalicylic acid—Nausea—Topotecan—peripheral nervous system neoplasm	0.000121	0.00102	CcSEcCtD
Acetylsalicylic acid—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00012	0.00102	CcSEcCtD
Acetylsalicylic acid—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00012	0.00101	CcSEcCtD
Acetylsalicylic acid—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00012	0.00101	CcSEcCtD
Acetylsalicylic acid—PTGS2—cerebellum—peripheral nervous system neoplasm	0.00012	0.0024	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00012	0.00101	CcSEcCtD
Acetylsalicylic acid—Nausea—Melphalan—peripheral nervous system neoplasm	0.000118	0.001	CcSEcCtD
Acetylsalicylic acid—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000996	CcSEcCtD
Acetylsalicylic acid—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000996	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000117	0.000989	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000117	0.000986	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000983	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000116	0.000977	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00097	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000113	0.000955	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.000954	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000922	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000922	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000109	0.000919	CcSEcCtD
Acetylsalicylic acid—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000916	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000909	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000107	0.000901	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000106	0.000898	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000888	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000105	0.000888	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000105	0.000886	CcSEcCtD
Acetylsalicylic acid—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000104	0.00088	CcSEcCtD
Acetylsalicylic acid—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000856	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000101	0.000854	CcSEcCtD
Acetylsalicylic acid—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000851	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.85e-05	0.000833	CcSEcCtD
Acetylsalicylic acid—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.81e-05	0.000829	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vincristine—peripheral nervous system neoplasm	9.76e-05	0.000825	CcSEcCtD
Acetylsalicylic acid—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.73e-05	0.000823	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000822	CcSEcCtD
Acetylsalicylic acid—Rash—Alitretinoin—peripheral nervous system neoplasm	9.65e-05	0.000816	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.64e-05	0.000815	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.61e-05	0.000813	CcSEcCtD
Acetylsalicylic acid—Urticaria—Etoposide—peripheral nervous system neoplasm	9.49e-05	0.000803	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000801	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	9.43e-05	0.000797	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vincristine—peripheral nervous system neoplasm	9.38e-05	0.000793	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000788	CcSEcCtD
Acetylsalicylic acid—Rash—Vincristine—peripheral nervous system neoplasm	9.3e-05	0.000787	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.29e-05	0.000786	CcSEcCtD
Acetylsalicylic acid—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.09e-05	0.000769	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.93e-05	0.000755	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.8e-05	0.000744	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000743	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000741	CcSEcCtD
Acetylsalicylic acid—Nausea—Vincristine—peripheral nervous system neoplasm	8.76e-05	0.000741	CcSEcCtD
Acetylsalicylic acid—Flushing—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.00074	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000738	CcSEcCtD
Acetylsalicylic acid—Pruritus—Etoposide—peripheral nervous system neoplasm	8.45e-05	0.000715	CcSEcCtD
Acetylsalicylic acid—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.29e-05	0.000701	CcSEcCtD
Acetylsalicylic acid—Rash—Cisplatin—peripheral nervous system neoplasm	8.22e-05	0.000695	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.22e-05	0.000695	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.18e-05	0.000691	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000688	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000685	CcSEcCtD
Acetylsalicylic acid—Dizziness—Etoposide—peripheral nervous system neoplasm	7.9e-05	0.000668	CcSEcCtD
Acetylsalicylic acid—Nausea—Cisplatin—peripheral nervous system neoplasm	7.75e-05	0.000655	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etoposide—peripheral nervous system neoplasm	7.6e-05	0.000642	CcSEcCtD
Acetylsalicylic acid—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000641	CcSEcCtD
Acetylsalicylic acid—Agitation—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000638	CcSEcCtD
Acetylsalicylic acid—Rash—Etoposide—peripheral nervous system neoplasm	7.54e-05	0.000637	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.53e-05	0.000637	CcSEcCtD
Acetylsalicylic acid—ABCB1—cerebellum—peripheral nervous system neoplasm	7.4e-05	0.00148	CbGeAlD
Acetylsalicylic acid—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000624	CcSEcCtD
Acetylsalicylic acid—Syncope—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.000621	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.00061	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.000601	CcSEcCtD
Acetylsalicylic acid—Nausea—Etoposide—peripheral nervous system neoplasm	7.1e-05	0.0006	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000599	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000594	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.99e-05	0.000591	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.99e-05	0.000591	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.00059	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000577	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000576	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.000575	CcSEcCtD
Acetylsalicylic acid—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000571	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000566	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000564	CcSEcCtD
Acetylsalicylic acid—Shock—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000557	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000556	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000555	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000554	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000553	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000548	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.000547	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.000547	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000528	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000524	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000516	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000513	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.000512	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000507	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.97e-05	0.000505	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000504	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000499	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000467	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.52e-05	0.000467	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000466	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000461	CcSEcCtD
Acetylsalicylic acid—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.00045	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.000432	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.94e-05	0.000417	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000416	CcSEcCtD
Acetylsalicylic acid—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000401	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000388	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000386	CcSEcCtD
Acetylsalicylic acid—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000375	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000371	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.26e-05	0.00036	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000359	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000357	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000357	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000347	CcSEcCtD
Acetylsalicylic acid—Nausea—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000336	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.94e-05	0.000333	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.00033	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.00033	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000311	CcSEcCtD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	2.07e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	2.07e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	2.07e-05	0.000196	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—GNS—peripheral nervous system neoplasm	2.05e-05	0.000194	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.04e-05	0.000193	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.04e-05	0.000193	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—CASP3—peripheral nervous system neoplasm	2e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	1.99e-05	0.000189	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.99e-05	0.000189	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.97e-05	0.000187	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	1.97e-05	0.000186	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—HRAS—peripheral nervous system neoplasm	1.95e-05	0.000185	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.94e-05	0.000184	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	1.93e-05	0.000183	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.93e-05	0.000183	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.93e-05	0.000182	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.92e-05	0.000182	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.92e-05	0.000182	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—ERBB2—peripheral nervous system neoplasm	1.9e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.89e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.89e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	1.89e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	1.88e-05	0.000178	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—PTPN11—peripheral nervous system neoplasm	1.86e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.81e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	1.8e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000164	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000164	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—HRAS—peripheral nervous system neoplasm	1.73e-05	0.000164	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—AKT1—peripheral nervous system neoplasm	1.73e-05	0.000163	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.72e-05	0.000163	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	1.72e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	1.71e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	1.7e-05	0.000161	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.68e-05	0.00016	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.68e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—NRAS—peripheral nervous system neoplasm	1.68e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—HRAS—peripheral nervous system neoplasm	1.67e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.66e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.66e-05	0.000157	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	1.66e-05	0.000157	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ERBB2—peripheral nervous system neoplasm	1.65e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNB1—peripheral nervous system neoplasm	1.65e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	1.64e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000154	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.6e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HRAS—peripheral nervous system neoplasm	1.6e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.6e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.59e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—PTPN11—peripheral nervous system neoplasm	1.59e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	1.59e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	1.58e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.58e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.57e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.54e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.54e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	1.53e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—AKT1—peripheral nervous system neoplasm	1.53e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.51e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ERBB2—peripheral nervous system neoplasm	1.47e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—AKT1—peripheral nervous system neoplasm	1.47e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.45e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NRAS—peripheral nervous system neoplasm	1.45e-05	0.000137	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	1.43e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.43e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.41e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.41e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.41e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.4e-05	0.000132	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.39e-05	0.000132	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.39e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.35e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MYC—peripheral nervous system neoplasm	1.35e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.34e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.34e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.33e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.33e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.33e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	1.31e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.31e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.29e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.28e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.28e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.28e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HGF—peripheral nervous system neoplasm	1.27e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.27e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—ERBB2—peripheral nervous system neoplasm	1.26e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—NRAS—peripheral nervous system neoplasm	1.25e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	1.25e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.25e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	1.24e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—HRAS—peripheral nervous system neoplasm	1.23e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.23e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.23e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.22e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.21e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	1.21e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.21e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.21e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.19e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.17e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.16e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.16e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.15e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.15e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.14e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.14e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.12e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NRAS—peripheral nervous system neoplasm	1.12e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	1.11e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.09e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.08e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.07e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—peripheral nervous system neoplasm	1.06e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.06e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.05e-05	9.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.05e-05	9.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	1.04e-05	9.85e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	1.04e-05	9.84e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.02e-05	9.66e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.01e-05	9.59e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	1e-05	9.47e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1e-05	9.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.87e-06	9.34e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.78e-06	9.27e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.68e-06	9.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NRAS—peripheral nervous system neoplasm	9.57e-06	9.07e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.56e-06	9.06e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.53e-06	9.02e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.53e-06	9.02e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.44e-06	8.94e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.4e-06	8.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	9.35e-06	8.85e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—AKT1—peripheral nervous system neoplasm	9.34e-06	8.85e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTPN11—peripheral nervous system neoplasm	9.27e-06	8.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	9.19e-06	8.71e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—peripheral nervous system neoplasm	9.18e-06	8.69e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.98e-06	8.5e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.98e-06	8.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	8.78e-06	8.32e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.73e-06	8.27e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.65e-06	8.19e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.65e-06	8.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.63e-06	8.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	8.49e-06	8.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	8.46e-06	8.01e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	8.41e-06	7.96e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.38e-06	7.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.33e-06	7.89e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	8.26e-06	7.82e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.21e-06	7.78e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—peripheral nervous system neoplasm	8.2e-06	7.77e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.11e-06	7.68e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—AKT1—peripheral nervous system neoplasm	8.1e-06	7.67e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.02e-06	7.59e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.93e-06	7.51e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.93e-06	7.51e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—AKT1—peripheral nervous system neoplasm	7.82e-06	7.41e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.75e-06	7.34e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.55e-06	7.15e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.55e-06	7.15e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.47e-06	7.07e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.41e-06	7.02e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.37e-06	6.98e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB2—peripheral nervous system neoplasm	7.33e-06	6.94e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.25e-06	6.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.25e-06	6.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—AKT1—peripheral nervous system neoplasm	7.24e-06	6.86e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	7.15e-06	6.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	7.11e-06	6.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	7.04e-06	6.67e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—peripheral nervous system neoplasm	7e-06	6.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.94e-06	6.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	6.88e-06	6.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.82e-06	6.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.78e-06	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.75e-06	6.4e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.75e-06	6.4e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	6.74e-06	6.38e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	6.73e-06	6.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	6.72e-06	6.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TH—peripheral nervous system neoplasm	6.68e-06	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.61e-06	6.26e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.54e-06	6.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.38e-06	6.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.23e-06	5.9e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.2e-06	5.88e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—peripheral nervous system neoplasm	6.18e-06	5.86e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.08e-06	5.76e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6e-06	5.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6e-06	5.68e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.94e-06	5.62e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	5.94e-06	5.62e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.93e-06	5.62e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.86e-06	5.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.85e-06	5.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.82e-06	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	5.62e-06	5.32e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	5.59e-06	5.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—peripheral nervous system neoplasm	5.58e-06	5.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.55e-06	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.55e-06	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.55e-06	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5.48e-06	5.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.47e-06	5.18e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	5.45e-06	5.17e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.38e-06	5.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	5.35e-06	5.07e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.3e-06	5.02e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.3e-06	5.02e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.24e-06	4.96e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.18e-06	4.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	4.9e-06	4.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.8e-06	4.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.78e-06	4.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.74e-06	4.49e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.68e-06	4.44e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.68e-06	4.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.46e-06	4.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	4.42e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.38e-06	4.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.3e-06	4.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	4.3e-06	4.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	4.11e-06	3.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—peripheral nervous system neoplasm	4.08e-06	3.86e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	3.63e-06	3.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.61e-06	3.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—peripheral nervous system neoplasm	3.6e-06	3.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	3.36e-06	3.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.36e-06	3.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—peripheral nervous system neoplasm	3.13e-06	2.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.76e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.64e-06	2.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	2.46e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.33e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	2.29e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	2.17e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	1.82e-06	1.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.48e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.47e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.32e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.29e-06	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.2e-06	1.14e-05	CbGpPWpGaD
